Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: Treatment success was achieved in 6 patients (75%), with resolution of lymphoceles assessed with clinical and imaging findings. Four patients (50%) required 2 applications of fibrin sealant, with 2 (25%) subsequently requiring surgical management of the lymphoceles. Clinical followup averaged 27.7 months (range 4 to 44). Complications included lymphocele recurrence, clogging of drainage catheters and catheter dislodgement. CONCLUSIONS: The experience of 8 patients suggests that fibrin glue sclerotherapy may be considered a safe and effective method of treating symptomatic lymphoceles when simple percutaneous drainage has failed. The percutaneous approach does not require hospital admission and is less invasive than surgical treatment.
|
Authors | Arnold i Chin, Nagesh Ragavendra, Lee Hilborne, H Albin Gritsch |
Journal | The Journal of urology
(J Urol)
Vol. 170
Issue 2 Pt 1
Pg. 380-3
(Aug 2003)
ISSN: 0022-5347 [Print] United States |
PMID | 12853780
(Publication Type: Journal Article)
|
Chemical References |
- Fibrin Tissue Adhesive
- Tissue Adhesives
|
Topics |
- Adolescent
- Adult
- Female
- Fibrin Tissue Adhesive
(adverse effects, therapeutic use)
- Humans
- Kidney Transplantation
(adverse effects)
- Lymphocele
(diagnostic imaging, etiology, therapy)
- Male
- Middle Aged
- Retrospective Studies
- Sclerotherapy
- Tissue Adhesives
(adverse effects, therapeutic use)
- Ultrasonography
|